BT Catalyst

View more issues:

Articles in March-April, 2007 issue of BT Catalyst

• Triad BioNight honors biotech leaders, energizes region
• Pozen
• Hatteras Venture Partners
• Inspire Pharmaceuticals of Durham has signed an exclusive licensing agreement with InSite Vision of Alameda, Calif
• Cheryl McMurry, director of the North Carolina Biotechnology Center's Western office in Asheville, was honored in February by the North Carolina Career Network for her career achievements
• SEBIO sets BIO/Plan competition
• Six NC health care firms in CED Venture event
• Inspire Pharmaceuticals
• Icagen
• Diosynth Biotechnology
• Targacept
• Bush touts biofuels in Novozymes visit
• Gorbec Pharmaceutical Services of Durham
• Alphamed Press
• TransTech Pharma of High Point has obtained exclusive worldwide rights to the clinical glucokinase activator program of Novo Nordisk of Bagsvaerd, Denmark, including preclinical and clinical compounds
• First Flight Venture Center
• Flutrends International
• NC's biotech draws kudos
• Chiltern International of Carlsbad
• AlphaVax
• SmartGene of Raleigh has entered into a strategic collaboration with laboratory Corporation of America whereby lab-Corp will use SmartGene's advanced technology
• Cardinal Health has reached an agreement to sell its Pharmaceutical Technologies and Services segment to The Blackstone Group for approximately $3.3 billion in cash
• Stephanie Adams takes SEBIO helm
• Amphora Discovery Corp
• NewGen Technologies of Charlotte has secured $70 million in secured debt financing from BioFuel Investments
• Qualyst
• Athenix Corp
• Nationwide search gets under way for Biotechnology Center president
• Community College System's BioNetwork
• PPD
• PPD of Wilmington has acquired from Ranbaxy Laboratories of Gurgaon
• 2007 First Citizens Bank Scholars Medal
• INC Research
• National SBIR funding conference set for RTP
• Medcath
• Chimerix of Durham has raised $23.1 million in a private placement of its Series D preferred stock to start clinical trials of its antiviral treatment for smallpox and cytomegalovirus
• Laboratory Corporation of America of Burlington and ARCA Discovery of Denver have entered into an exclusive collaboration to develop a commercial genetic test to aid in prescribing bucindolol
• Advanced Liquid Logic of Morrisville has acquired Nanolytics of Raleigh for an undisclosed price
• Calendar
• Biotechnology bibliotheca
• Metabolon
• Salix Pharmaceuticals of Raleigh has entered into a credit facility with Bank of America for up to $100 million to help finance the purchase of two drugs from Merck & Co. and for working capital, capital expenditures, other acquisitions and general co
• SCYNEXIS
• Quintiles Transnational
• Hatteras Venture Partners
• North Carolina Biotechnology Center
• Oncogenomics
• Vesta Therapeutics of Durham has signed a strategic collaboration agreement with Cytonet GmbH & Co of Weinheim
• Expression Analysis
• Diosynth Biotechnology
• Intersouth Partners
• Salix Pharmaceuticals of Raleigh has purchased the U.S. prescription pharmaceutical product rights to Pepcid® Oral Suspension and Diuril® oral Suspension from Merck & Co
• Staffing company Headway Corporate Resources of Tarboro has entered into a partnership with biomedical technology consulting firm Scintellix
• SSOE